Evidence map›Paper›PMID 31489369›Full record

ArticleScience advances2019

Inhibition of mitochondrial permeability transition by deletion of the ANT family and CypD.

Jason Karch, Michael J Bround, Hadi Khalil, Michelle A Sargent, Nadina Latchman, Naohiro Terada, Pablo M Peixoto, Jeffery D Molkentin

Open access · goldAbstract read
In one paragraph

Article in Science advances, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 148 papers.

0numbers the graph read from it
0cells of the map it votes in
148citing papers in PubMed
11.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

148 citing papers in PubMed, 233 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. The two faces of mitochondrial CaJournal of physiology and biochemistry · 2026
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Phenotypic CRISPR screens identify NLRX1 as an essential activator of the human mitochondrial permeability transition.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article

88 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Jason KarchDepartment of Pediatrics, Cincinnati Children's Hospital and University of Cincinnati, Cincinnati, OH, USA.ORCID 0000-0002-3023-7469
Michael J BroundDepartment of Pediatrics, Cincinnati Children's Hospital and University of Cincinnati, Cincinnati, OH, USA.ORCID 0000-0003-3238-5489
Hadi KhalilDepartment of Pediatrics, Cincinnati Children's Hospital and University of Cincinnati, Cincinnati, OH, USA.
Michelle A SargentDepartment of Pediatrics, Cincinnati Children's Hospital and University of Cincinnati, Cincinnati, OH, USA.
Nadina LatchmanBaruch College and Graduate Center of City University of New York, NY, USA.ORCID 0000-0003-4161-3770
Naohiro TeradaDepartment of Pathology, University of Florida College of Medicine, Gainesville, FL, USA.
Pablo M PeixotoBaruch College and Graduate Center of City University of New York, NY, USA.ORCID 0000-0001-5953-6027
Jeffery D MolkentinDepartment of Pediatrics, Cincinnati Children's Hospital and University of Cincinnati, Cincinnati, OH, USA.ORCID 0000-0002-3558-6529
Cincinnati Children's Hospital Medical Center · USThe Graduate Center, CUNY · USUniversity of Florida · US

Funding

Molecular examination of mitochondrial calcium controlR01HL132831 · NHLBI · CINCINNATI CHILDRENS HOSP MED CTR · PI BERS, DONALD M, MOLKENTIN, JEFFERY D · 2016 to 2024
$5.9M
Retraction or reshaping: dissecting the role of mitochondrial ROS in synaptic plasticitySC1GM136609 · NIGMS · BERNARD M. BARUCH COLLEGE · PI PEIXOTO, PABLO M · 2020 to 2023
$1.4M
Howard Hughes Medical InstituteNHLBI NIH HHS R01 HL132831NIGMS NIH HHS SC1 GM136609
6 · The paper itself

Abstract

The mitochondrial permeability transition pore (MPTP) has resisted molecular identification. The original model of the MPTP that proposed the adenine nucleotide translocator (ANT) as the inner membrane pore-forming component was challenged when mitochondria from Ant1/2 double null mouse liver still had MPTP activity. Because mice express three

Indexed as

Adenine NucleotidesAnimalsCells, CulturedFemaleMaleMiceMice, KnockoutMitochondriaMitochondrial Membrane Transport ProteinsMitochondrial Permeability Transition PoreMitochondrial Transmembrane Permeability-Driven NecrosisPeptidyl-Prolyl Isomerase FSequence DeletionAdenine NucleotidesMitochondrial Membrane Transport ProteinsMitochondrial Permeability Transition PorePeptidyl-Prolyl Isomerase F

Identifiers

PMID31489369
PMCPMC6713508
OpenAlexW2970506751

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.